AIM
RVMD icon

Aigen Investment Management’s Revolution Medicines RVMD Stock Holding History

Aigen Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,129
Closed -$647K – 755
2025
Q4 		$647K Sell
8,129
-11,117
-58% -$729K 0.15% 207
2025
Q3 		$899K Buy
19,246
+4,621
+32% +$181K 0.14% 227
2025
Q2 		$538K Buy
14,625
+2,701
+23% +$104K 0.07% 387
2025
Q1 		$422K Buy
+11,924
New +$484K 0.07% 395
2024
Q3 		– Sell
-8,660
Closed -$336K – 974
2024
Q2 		$336K Buy
+8,660
New +$324K 0.07% 440
2023
Q4 		– Sell
-21,071
Closed -$583K – 1043
2023
Q3 		$583K Buy
+21,071
New +$625K 0.11% 307

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return